Clinical research in Nepal
A country-level research partner built for rigorous delivery
Anweshan supports pharmaceutical, biotech, global CRO, academic and global-health partners with clinical and biomedical research in Nepal, from feasibility and ethics coordination through site operations, data, quality and publication support.
Why Nepal and why Anweshan
Research shaped by local realities.
Nepal offers diverse study settings, established referral hospitals, experienced clinicians and important unanswered questions across infectious disease, maternal and newborn health, reproductive health, noncommunicable disease, antimicrobial resistance, disability and implementation science. Successful research here depends on more than access to sites. It requires a partner that understands national institutions, ethics and regulatory pathways, hospital workflows, language, field logistics, data conditions and community expectations. Anweshan brings those pieces together through a Nepal-based multidisciplinary team and a growing business-development presence in Basel.
Who we work with
A practical partner for different research teams.
- Pharmaceutical and biotechnology companies exploring studies in Nepal
- Global and regional CROs seeking an accountable country partner
- Universities, hospitals and investigator-led research groups
- Vaccine, diagnostics, antimicrobial and public-health research programmes
- Foundations and product-development partnerships conducting implementation or real-world research
Support across the study lifecycle
Coordinated support from first questions to shared findings.
Strategy and feasibility
Country and site landscape review, epidemiological and care-pathway context, investigator and site outreach, operational feasibility, recruitment assumptions, cost and timeline inputs, and risk mapping.
Start-up, ethics and regulatory coordination
Local document preparation, submission coordination, translation and back-translation, responses and version control, import or product-related coordination where applicable, and start-up tracking. Formal sponsor and investigator responsibilities remain clearly assigned.
Site identification and activation
Site qualification support, workflow and resource assessment, study-team mapping, site agreements, initiation planning, training logistics and readiness documentation.
Participant and community materials
Context-sensitive consent and participant materials, linguistic review, community engagement planning, recruitment communication and comprehension testing.
Study and field operations
Country coordination, site support, study logistics, participant tracking processes, field-team deployment, training, documentation, issue escalation and operational reporting.
Data management and biostatistics
Database and electronic data-capture support, data dictionaries, data-quality rules, cleaning, query management, statistical analysis and reproducible tables and outputs.
Monitoring and quality
Risk-based monitoring support, source and process checks, deviation and issue tracking, corrective and preventive action support, essential-document control, audit readiness and quality reporting.
Safety and pharmacovigilance support
Local safety workflow coordination, reporting pathways, reconciliation and follow-up support when the required qualified personnel, agreements and SOPs are in place.
Medical writing and publication
Protocols, study reports, abstracts, manuscripts, evidence synthesis, submission support and public-facing research communication with transparent authorship.
Real-world and implementation research
Post-introduction studies, health-facility research, service and pathway assessments, mixed-method implementation studies and evidence for scale-up.
Experience that supports this direction
Relevant experience across studies, sites and datasets.
Evidence
SUSTAIN stepped-wedge cluster-randomised study in eight public hospitals
What it demonstrates: Multi-site research, process evaluation and work within maternal/newborn care settings
Evidence
CAPTURA AMR work across 28 laboratories and more than 660,000 isolate records
What it demonstrates: Site engagement, data transfer, large health datasets, curation, analysis and publication
Evidence
National abortion-incidence study covering 767 health facilities and 231 key informants
What it demonstrates: Large multi-source reproductive-health research and national coordination
Evidence
Ear and hearing study in Karnali with 1,946 participants in the analysed sample
What it demonstrates: Community-based biomedical assessment, field quality and peer-reviewed publication
Evidence
Eye-care analysis using 43,848 records from 23 hospitals across seven provinces
What it demonstrates: Multi-site secondary data analysis and real-world service evidence
Evidence
Health-facility assessments, hospital readiness work and digital-health assignments
What it demonstrates: Operational research across facilities, workflows, systems and users
Areas of experience
Questions that matter across Nepal.
- Maternal, newborn and reproductive health
- Vaccines, infectious disease and outbreak response
- Antimicrobial resistance and antimicrobial use
- Eye, ear, hearing and disability research
- Health systems, digital health and implementation science
- Cancer-care access and noncommunicable disease
- Migration health and occupational health
Quality and compliance
Clear responsibilities. Traceable decisions.
Quality is designed into the study from the beginning. We define responsibilities, document workflows, control versions, train teams, monitor critical processes and keep decisions traceable. Study-specific quality arrangements are aligned with the protocol, sponsor requirements, applicable ethics and regulatory approvals, data-protection obligations and recognised good clinical practice principles.
Before an engagement begins, we agree the oversight model, data flows, escalation routes, safety responsibilities, essential documents and quality indicators. Where a function requires a licensed or qualified role, we identify and document that responsibility rather than implying it is covered by a general project team.
Basel to Nepal
A direct bridge between European sponsors and research delivery in Nepal
Anweshan's presence in Basel creates a practical point of contact for European life-sciences and research organisations considering Nepal. Sponsors can discuss feasibility, quality expectations and partnership structures in Europe while working with an established Nepal-based team for country intelligence, stakeholder coordination and delivery. The purpose is simple: reduce the distance between sponsor expectations and the realities that determine study performance on the ground.
Study feasibility enquiry
Planning a study in Nepal?
Send us the protocol synopsis, target population, site assumptions and expected timeline. We will respond with the questions needed for a focused feasibility discussion.
Capability pack
Request our capability pack.
Tell us a little about your organisation and how you plan to use the pack. We will follow up by email.